{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T05:38:14Z","timestamp":1789623494545,"version":"build-2803163510"},"reference-count":26,"publisher":"American Association for Cancer Research (AACR)","issue":"6","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2006,3,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Human melanoma susceptibility is often characterized by germ-line inactivating CDKN2A (INK4A\/ARF) mutations, or mutations that activate CDK4 by preventing its binding to and inhibition by INK4A. We have previously shown that a single neonatal UV radiation (UVR) dose delivered to mice that carry melanocyte-specific activation of Hras (TPras) increases melanoma penetrance from 0% to 57%. Here, we report that activated Cdk4 cooperates with activated Hras to enhance susceptibility to melanoma in mice. Whereas UVR treatment failed to induce melanomas in Cdk4R24C\/R24C mice, it greatly increased the penetrance and decreased the age of onset of melanoma development in Cdk4R24C\/R24C\/TPras animals compared with TPras alone. This increased penetrance was dependent on the threshold of Cdk4 activation as Cdk4R24C\/+\/TPras animals did not show an increase in UVR-induced melanoma penetrance compared with TPras alone. In addition, Cdk4R24C\/R24C\/TPras mice invariably developed multiple lesions, which occurred rarely in TPras mice. These results indicate that germ-line defects abrogating the pRb pathway may enhance UVR-induced melanoma. TPras and Cdk4R24C\/R24C\/TPras tumors were comparable histopathologically but the latter were larger and more aggressive and cultured cells derived from such melanomas were also larger and had higher levels of nuclear atypia. Moreover, the melanomas in Cdk4R24C\/R24C\/TPras mice, but not in TPras mice, readily metastasized to regional lymph nodes. Thus, it seems that in the mouse, Hras activation initiates UVR-induced melanoma development whereas the cell cycle defect introduced by mutant Cdk4 contributes to tumor progression, producing more aggressive, metastatic tumors. (Cancer Res 2006; 66(6): 2946-52)<\/jats:p>","DOI":"10.1158\/0008-5472.can-05-3196","type":"journal-article","created":{"date-parts":[[2006,3,15]],"date-time":"2006-03-15T17:23:19Z","timestamp":1142443399000},"page":"2946-2952","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Spontaneous and UV Radiation\u2013Induced Multiple Metastatic Melanomas in\n                    <i>Cdk4R24C\/R24C\/TPras<\/i>\n                    Mice"],"prefix":"10.1158","volume":"66","author":[{"given":"Elke","family":"Hacker","sequence":"first","affiliation":[{"name":"1Queensland Institute of Medical Research;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Konrad","family":"Muller","sequence":"additional","affiliation":[{"name":"3University of Tasmania, School of Medicine, Hobart, Tasmania, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Irwin","sequence":"additional","affiliation":[{"name":"1Queensland Institute of Medical Research;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Gabrielli","sequence":"additional","affiliation":[{"name":"2Centre for Immunology and Cancer Research, Brisbane, Queensland, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas","family":"Lincoln","sequence":"additional","affiliation":[{"name":"1Queensland Institute of Medical Research;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Pavey","sequence":"additional","affiliation":[{"name":"1Queensland Institute of Medical Research;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne Broome","family":"Powell","sequence":"additional","affiliation":[{"name":"4Division of Radiation and Cancer Biology, Stanford University, Stanford, California; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos","family":"Malumbres","sequence":"additional","affiliation":[{"name":"5Molecular Oncology, Centro Nacional de Investigaciones Oncolo\u0301gicas, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariano","family":"Barbacid","sequence":"additional","affiliation":[{"name":"5Molecular Oncology, Centro Nacional de Investigaciones Oncolo\u0301gicas, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Hayward","sequence":"additional","affiliation":[{"name":"1Queensland Institute of Medical Research;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graeme","family":"Walker","sequence":"additional","affiliation":[{"name":"1Queensland Institute of Medical Research;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2006,3,15]]},"reference":[{"key":"2022061622115658900_B1","doi-asserted-by":"crossref","unstructured":"Noonan FP, Recio JA, Takayama H, et al. Neonatal sunburn and melanoma in mice. Nature\u20082001; 413: 271\u20132.","DOI":"10.1038\/35095108"},{"key":"2022061622115658900_B2","doi-asserted-by":"crossref","unstructured":"Broome Powell M, Gause PR, Hyman P, et al. Induction of melanoma in TPras transgenic mice. Carcinogenesis\u20081999; 20: 1747\u201353.","DOI":"10.1093\/carcin\/20.9.1747"},{"key":"2022061622115658900_B3","doi-asserted-by":"crossref","unstructured":"Hacker EI, Muller N, Broome HK, et al. Neonatal ultraviolet radiation exposure is critical for malignant melanoma induction in pigmented TPras transgenic mice. J Invest Dermatol\u20082005; 125: 1074\u20137.","DOI":"10.1111\/j.0022-202X.2005.23917.x"},{"key":"2022061622115658900_B4","doi-asserted-by":"crossref","unstructured":"Zhang Y, Xiong Y, Yarbrough WG. ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways. Cell\u20081998; 92: 725\u201334.","DOI":"10.1016\/S0092-8674(00)81401-4"},{"key":"2022061622115658900_B5","doi-asserted-by":"crossref","unstructured":"Molven A, Grimstvedt MB, Steine SJ, et al. A large Norwegian family with inherited malignant melanoma, multiple atypical nevi, and CDK4 mutation. Genes Chromosomes Cancer\u20082005; 44: 10\u20138.","DOI":"10.1002\/gcc.20202"},{"key":"2022061622115658900_B6","doi-asserted-by":"crossref","unstructured":"Zuo L, Weger J, Yang Q, et al. Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma. Nat Genet\u20081996; 12: 97\u20139.","DOI":"10.1038\/ng0196-97"},{"key":"2022061622115658900_B7","doi-asserted-by":"crossref","unstructured":"de Snoo FA, Hayward NK. Cutaneous melanoma susceptibility and progression genes. Cancer Lett\u20082005; 230: 153\u201386.","DOI":"10.1016\/j.canlet.2004.12.033"},{"key":"2022061622115658900_B8","unstructured":"Dong J, Phelps RG, Qiao R, et al. BRAF oncogenic mutations correlate with progression rather than initiation of human melanoma. Cancer Res\u20082003; 63: 3883\u20135."},{"key":"2022061622115658900_B9","doi-asserted-by":"crossref","unstructured":"Cohen Y, Rosenbaum E, Begum S, et al. Exon 15 BRAF mutations are uncommon in melanomas arising in nonsun-exposed sites. Clin Cancer Res\u20082004; 10: 3444\u20137.","DOI":"10.1158\/1078-0432.CCR-03-0562"},{"key":"2022061622115658900_B10","doi-asserted-by":"crossref","unstructured":"Maldonado JL, Fridlyand J, Patel H, et al. Determinants of BRAF mutations in primary melanomas. J Natl Cancer Inst\u20082003; 95: 1878\u201390.","DOI":"10.1093\/jnci\/djg123"},{"key":"2022061622115658900_B11","doi-asserted-by":"crossref","unstructured":"Ackermann J, Frutschi M, Kaloulis K, McKee T, Trumpp A, Beermann F. Metastasizing melanoma formation caused by expression of activated N-RasQ61K on an INK4a-deficient background. Cancer Res\u20082005; 65: 4005\u201311.","DOI":"10.1158\/0008-5472.CAN-04-2970"},{"key":"2022061622115658900_B12","doi-asserted-by":"crossref","unstructured":"Patton EE, Widlund HR, Kutok JL, et al. BRAF mutations are sufficient to promote nevi formation and cooperate with p53 in the genesis of melanoma. Curr Biol\u20082005; 15: 249\u201354.","DOI":"10.1016\/j.cub.2005.01.031"},{"key":"2022061622115658900_B13","doi-asserted-by":"crossref","unstructured":"Krimpenfort P, Quon KC, Mooi WJ, Loonstra A, Berns A. Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice. Nature\u20082001; 413: 83\u20136.","DOI":"10.1038\/35092584"},{"key":"2022061622115658900_B14","doi-asserted-by":"crossref","unstructured":"Sharpless NE, Bardeesy N, Lee KH, et al. Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis. Nature\u20082001; 413: 86\u201391.","DOI":"10.1038\/35092592"},{"key":"2022061622115658900_B15","doi-asserted-by":"crossref","unstructured":"Kamijo T, Zindy F, Roussel MF, et al. Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF. Cell\u20081997; 91: 649\u201359.","DOI":"10.1016\/S0092-8674(00)80452-3"},{"key":"2022061622115658900_B16","doi-asserted-by":"crossref","unstructured":"Walker GJ, Hayward NK. Pathways to melanoma development: lessons from the mouse. J Invest Dermatol\u20082002; 119: 783\u201392.","DOI":"10.1046\/j.1523-1747.2002.00217.x"},{"key":"2022061622115658900_B17","doi-asserted-by":"crossref","unstructured":"Kannan K, Sharpless NE, Xu J, O'Hagan RC, Bosenberg M, Chin L. Components of the Rb pathway are critical targets of UV mutagenesis in a murine melanoma model. Proc Natl Acad Sci U S A\u20082003; 100: 1221\u20135.","DOI":"10.1073\/pnas.0336397100"},{"key":"2022061622115658900_B18","doi-asserted-by":"crossref","unstructured":"Rane SG, Dubus P, Mettus RV, et al. Loss of Cdk4 expression causes insulin-deficient diabetes and Cdk4 activation results in \u03b2-islet cell hyperplasia. Nat Genet\u20081999; 22: 44\u201352.","DOI":"10.1038\/8751"},{"key":"2022061622115658900_B19","doi-asserted-by":"crossref","unstructured":"Sotillo R, Garcia JF, Ortega S, et al. Invasive melanoma in Cdk4-targeted mice. Proc Natl Acad Sci U S A\u20082001; 98: 13312\u20137.","DOI":"10.1073\/pnas.241338598"},{"key":"2022061622115658900_B20","doi-asserted-by":"crossref","unstructured":"Gabrielli BG, De Souza CP, Tonks ID, Clark JM, Hayward NK, Ellem KA. Cytoplasmic accumulation of cdc25B phosphatase in mitosis triggers centrosomal microtubule nucleation in HeLa cells. J Cell Sci\u20081996; 109: 1081\u201393.","DOI":"10.1242\/jcs.109.5.1081"},{"key":"2022061622115658900_B21","doi-asserted-by":"crossref","unstructured":"Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res\u20082001; 29: e45.","DOI":"10.1093\/nar\/29.9.e45"},{"key":"2022061622115658900_B22","doi-asserted-by":"crossref","unstructured":"Crowe ML. SeqDoC: rapid SNP and mutation detection by direct comparison of DNA sequence chromatograms. BMC Bioinformatics\u20082005; 6: 133.","DOI":"10.1186\/1471-2105-6-133"},{"key":"2022061622115658900_B23","doi-asserted-by":"crossref","unstructured":"Sharpless NE, Kannan K, Xu J, Bosenberg MW, Chin L. Both products of the mouse Ink4a\/Arf locus suppress melanoma formation in vivo. Oncogene\u20082003; 22: 5055\u20139.","DOI":"10.1038\/sj.onc.1206809"},{"key":"2022061622115658900_B24","doi-asserted-by":"crossref","unstructured":"Bardeesy N, Bastian BC, Hezel A, Pinkel D, DePinho RA, Chin L. Dual inactivation of RB and p53 pathways in RAS-induced melanomas. Mol Cell Biol\u20082001; 21: 2144\u201353.","DOI":"10.1128\/MCB.21.6.2144-2153.2001"},{"key":"2022061622115658900_B25","doi-asserted-by":"crossref","unstructured":"Sarkar-Agrawal P, Vergilis I, Sharpless NE, DePinho RA, Runger TM. Impaired processing of DNA photoproducts and ultraviolet hypermutability with loss of p16INK4a or p19ARF. J Natl Cancer Inst\u20082004; 96: 1790\u20133.","DOI":"10.1093\/jnci\/djh307"},{"key":"2022061622115658900_B26","doi-asserted-by":"crossref","unstructured":"Dang CV. c-Myc target genes involved in cell growth, apoptosis, and metabolism. Mol Cell Biol\u20081999; 19: 1\u201311.","DOI":"10.1128\/MCB.19.1.1"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/66\/6\/2946\/2559266\/2946.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/66\/6\/2946\/2559266\/2946.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T20:05:15Z","timestamp":1655409915000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/66\/6\/2946\/526831\/Spontaneous-and-UV-Radiation-Induced-Multiple"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3,15]]},"references-count":26,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2006,3,15]]},"published-print":{"date-parts":[[2006,3,15]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-05-3196","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.c.6494867.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6494867","asserted-by":"object"}],"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/0008-5472.22365809","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22365809.v1","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,3,15]]}}}